Reply to: “Ipragliflozin improves the hepatic outcomes of patients with diabetes with NAFLD”

Laurens A. van Kleef, Robert J. de Knegt*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

55 Downloads (Pure)
Original languageEnglish
Pages (from-to)2605-2606
Number of pages2
JournalHepatology Communications
Issue number9
Early online date20 May 2022
Publication statusPublished - Sept 2022

Bibliographical note

Funding Information:
Supported by the Foundation for Liver and Gastrointestinal Research, Rotterdam, the Netherlands

Cite this